Skip to main
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 41%
Buy 53%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare is a well-managed healthcare services organization with strong operational discipline, evidenced by its ability to flex costs during periods of disruption, as seen in the Winter storm disruptions in 1Q26. Additionally, its diversified business model with both hospital operations and outpatient facilities provides stability and growth potential. Despite some headwinds such as a decline in HIX (health insurance exchange) volumes, the company has maintained its 2026 guidance and has strong cash flow and a healthy balance sheet.

Bears say

Tenet Healthcare is facing several challenges, including inconsistent revenue growth due to weather-related disruptions and a decline in respiratory admissions. With its exposure to government-funded healthcare programs and potential policy changes, the company is also facing uncertainty and potential financial impacts. Additionally, the company's high reliance on acquisitions and expanding its ambulatory care segment may also pose risks, particularly in terms of integration and financial performance. Overall, these factors contribute to a negative outlook for the company's stock.

Tenet Healthcare (THC) has been analyzed by 17 analysts, with a consensus rating of Buy. 41% of analysts recommend a Strong Buy, 53% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 17 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of Jul 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $246.12, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $246.12, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.